Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program.

Combinations of beta-lactams plus aminoglycosides have been standard therapy for suspected infections in granulocytopenic cancer patients, especially those with profound long-lasting granulocytopenia. With the advent of new broad-spectrum bactericidal antibiotics such as extended-spectrum cephalospo...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Cometta, A, Calandra, T, Gaya, H, Zinner, S H, de Bock, R, Del Favero, A, Bucaneve, G, Crokaert, F, Kern, W V, Klastersky, J, Langenaeken, I, Micozzi, A, Padmos, A, Paesmans, M, Viscoli, C, Glauser, M P
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC163274/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8723449/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.40.5.1108
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!